Equity

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Glaxosmithkline Pharmaceuticals LtdIndustry : Pharmaceuticals - Multinational
BSE Code:500660 NSE Symbol: GLAXO P/E (TTM) :56.84
ISIN Demat:INE159A01016 Div & Yield %:1.5 EPS (TTM) :37.52
Book Value (RS) :91.3566062 Market Cap (Rs Cr.):36130.07 Face Value (RS) :10
    Change Company 
Particulars Quarter Ended
(Dec 2023)
Quarter Ended
(Dec 2022)
Quarter Ended
(% Var)
Sales 804.98 799.11 0.73
Other Income 28.34 23.60 20.08
PBIDT 82.54 240.03 -65.61
Interest 0.32 0.09 255.56
PBDT 82.22 239.94 -65.73
Depreciation 17.11 16.41 4.27
PBT 65.11 223.53 -70.87
Tax 31.32 69.01 -54.62
Deferred Tax -11.70 -9.51 0.00
PAT 45.49 164.03 -72.27

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)